Puneeth Indurlal
Puneeth Indurlal publishes mostly in Economics and Econometrics, Oncology and Immunology, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical Economics and Policy.
- World rank
- #4,742,217 of 7,710,434 ranked researchers
- Rank in United States
- #1,246,375 of 1,627,098
- Works
- 63
- Citations
- 20
- Citations per work
- 0.3
What does Puneeth Indurlal research?
Puneeth Indurlal's work is mostly in Economics, Econometrics and Finance (53%), Medicine (17%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences3352.6%
- Health Sciences1422.7%
- Medicine1117.5%
- Health Professions35.2%
- Everything else1117.6%
- Life Sciences47.1%
- 1Economics and Econometrics53% of their works
- 2Oncology10% of their works
- 3Immunology7% of their works
- 4Public Health, Environmental and Occupational Health5% of their works
- 5General Health Professions5% of their works
- 6Geriatrics and Gerontology3% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Palliative Care and End-of-Life Issues
- Primary Care and Health Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Global Cancer Incidence and Screening
Which keywords describe Puneeth Indurlal's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Biosimilars and Immunogenicity.
- Polypharmacy
- Inappropriate Medication Use
- Quality Improvement
- Palliative Care
- Immunogenicity
- Generic Drugs
- Quality of Life
- Financial Toxicity
- Cost of Care
- Cost-effectiveness Analysis
- Drug Development Costs
- Biosimilars
- End-of-Life
- Primary Care
- Cancer Incidence
- Mortality Rates
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost of Care351 topic
- Financial Toxicity351 topic
- Cost-effectiveness Analysis321 topic
- Quality of Life321 topic
- Drug Development Costs121 topic
- Generic Drugs121 topic
- Biosimilars111 topic
- Immunogenicity111 topic
- End-of-Life71 topic
- Palliative Care71 topic
- Primary Care51 topic
- Quality Improvement51 topic
- Cancer Incidence31 topic
- Inappropriate Medication Use31 topic
- Mortality Rates31 topic
- Polypharmacy31 topic
Where does Puneeth Indurlal work?
Puneeth Indurlal's main affiliation in the publication record is The US Oncology Network, United States.
How many publications and citations does Puneeth Indurlal have?
OpenAlex counts 63 works and 20 citations for Puneeth Indurlal, an h-index of 2, ranking #4,742,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Puneeth Indurlal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.